Patent Assignment
Reel/Frame 043074/0744
Confirmatory License
Recorded: 2017-07-03
Pages: 2
Assignor
OKLAHOMA MEDICAL RESEARCH FOUNDATION
Executed: 2017-06-30
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Novel Component of Von Hippel-Lindau Tumor Suppressor Complex and Scf Ubiquitin Ligase
Patent:
6,858,709 →
Application:
09/914,324 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 21, 2002
From: CONAWAY, JOAN W.; KAMURA, TAKUMI
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 012918/0569 →
Assignment of Assignor's Interest
May 21, 2002
From: CONAWAY, RONALD C.
To: OKLAHOMA MEDICAL RESEARCH FOUNDATION
Reel/Frame 012918/0796 →
Assignment of Assignor's Interest
May 21, 2002
From: HOWARD HUGHES MEDICAL INSTITUTE
To: OKLAHOMA MEDICAL RESEARCH FOUNDATION
Reel/Frame 012918/0801 →
Corrective Assignment to Correct the Execution Date: December 19, 1998 Previously Recorded on Reel 012918 Frame 0569. Assignor(S) Hereby Confirms the Execution Date: November 18, 1998 and November 19, 1998.
Jan 17, 2008
From: CONAWAY, JOAN W.; KAMURA, TAKUMI
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 020385/0213 →
Confirmatory License
Jun 30, 2017
From: OKLAHOMA MEDICAL RESEARCH FOUNDATION
To: NIH-DEITR
Reel/Frame 042879/0106 →